Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Antianxiety effect of cannabidiol in the elevated plus-maze

Antianxiety effect of cannabidiol in the elevated plus-maze 213 100 100 4 4 F. S. Guimarães T. M. Chiaretti F. G. Graeff A. W. Zuardi Department of Pharmacology Campus of the University of São Paulo BR 14049 Ribeirão Preto SP Brazil Department of Neuropsychiatry FMRP, Campus of the University of São Paulo BR 14049 Ribeirão Preto SP Brazil Laboratory of Psychobiology, FFCLRP Campus of the University of São Paulo BR 14049 Ribeirão Preto SP Brazil Abstract In order to assess the presence of anxiolytic properties in cannabidiol (CBD) the drug was tested in an elevated plus-maze model of anxiety, in rats. Doses of 2.5, 5.0 and 10.0 mg/kg significantly increased the entry ratio (open/total number of entries), an anxiolytic-like effect. CBD at a dose of 20.0 mg/kg was no longer effective. None of the doses of CBD used changed total number of entries, a measure of total exploratory activity. Diazepam (2.0 mg/kg) also caused an anxiolytic-like effect in this model. These results indicate that CBD causes a selective anxiolytic effect in the elevated plusmaze, within a limited range of doses. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Psychopharmacology Springer Journals

Antianxiety effect of cannabidiol in the elevated plus-maze

Loading next page...
 
/lp/springer-journals/antianxiety-effect-of-cannabidiol-in-the-elevated-plus-maze-rz0Yp6rAEb

References (6)

Publisher
Springer Journals
Copyright
Copyright © 1990 by Springer-Verlag
Subject
Biomedicine; Pharmacology/Toxicology; Psychiatry
ISSN
0033-3158
eISSN
1432-2072
DOI
10.1007/BF02244012
Publisher site
See Article on Publisher Site

Abstract

213 100 100 4 4 F. S. Guimarães T. M. Chiaretti F. G. Graeff A. W. Zuardi Department of Pharmacology Campus of the University of São Paulo BR 14049 Ribeirão Preto SP Brazil Department of Neuropsychiatry FMRP, Campus of the University of São Paulo BR 14049 Ribeirão Preto SP Brazil Laboratory of Psychobiology, FFCLRP Campus of the University of São Paulo BR 14049 Ribeirão Preto SP Brazil Abstract In order to assess the presence of anxiolytic properties in cannabidiol (CBD) the drug was tested in an elevated plus-maze model of anxiety, in rats. Doses of 2.5, 5.0 and 10.0 mg/kg significantly increased the entry ratio (open/total number of entries), an anxiolytic-like effect. CBD at a dose of 20.0 mg/kg was no longer effective. None of the doses of CBD used changed total number of entries, a measure of total exploratory activity. Diazepam (2.0 mg/kg) also caused an anxiolytic-like effect in this model. These results indicate that CBD causes a selective anxiolytic effect in the elevated plusmaze, within a limited range of doses.

Journal

PsychopharmacologySpringer Journals

Published: Apr 1, 1990

There are no references for this article.